TBL 3 - THE HUMAN MEDICINES REGULATIONS 2012 Flashcards
What is overview of the human medicines regulation 2012 (3 things)?
HMR state that medicines can only be supplied to the public from pharmacies with the exception of those medicines that can safely be sold without the supervision of a pharmacist.
HMR covers labelling of meds, the containers they are supplied in and how they are advertised.
Every step of the supply chain is regulated, manufacture, import, distribution , sale and supply, labelling, advertising and pharmacovigilance.
What is part 1 general provision about?
Description of the role of ministers and general definitions, including ‘medicinal product’ and advertisement.
What is the Part 4 - requirement of authorisation provision about?
Requirement that medicinal products subject to a marketing authorisation, homeopathic certificate of registration, traditional herbal registration (THR) or article 126a authorisation.
What is Part 5 - Marketing authorisations about?
Makes specific provisions for generic medicinal products, biological medicinal products, products with well-established medicinal use and new combinations of active substances.
Determine whether a product needs to be subject to prescription requirements.
Requirement to take into account scientific and technical progress and contains rules relating to revocation, variation, suspension, withdrawal of authorisation.
Paediatric regulation
What is Part 6 - Certification of homeopathic medicinal products about?
Sets out info that must be supplied with an application for a certificate of registration
Sets out rules regarding revocation, withdrawals, and suspensions
What is the Part 7 - traditional herbal registrations about?
Describes the traditional herbal medicinal products to which it applies and sets out info that must be supplied with an application for a traditional herbal registration.
Sets out rules regarding revocation, variation, withdrawals and suspensions.
What is the Part 9 - Borderline products about?
Licensing authority determines provisionally product is a medicinal product and therefore subject to regulation as such.
Permits person supplying product to make written and oral representations to the contrary and for final determinations.
What is the Part 10 - exception to requirement for marketing authorisation about?
Provision of specials
These are unlicensed medicinal products that can be supplied providing that certain conditions are met.
Provision for parallel import licences and provides an exemption from marketing authorisation requirements for advance therapy medicinal products and the supply of unlicensed medicines in response to the spread of toxic substances or nuclear radiation.
What is Part 11 - pharmacovigilance about?
Imposes obligations on authorisation holders and licensing authority in relation to pharmacovigilance (the monitoring of the safety of medicines in clinical use and taking appropriate action to minimise risk)
What is Part 12 - dealings with medicinal products about?
Sale supply and adminsteration of medicinal products related to their classification as GSL, P and POM
Exemption from basic rules for hospitals , certain professionals and supply under patient group directions (PGDs)
What is Part 13 - packaging and leaflets about?
Info that must appear on packaging and in leaflets and contains specific rules for braille, radionuclides and homeopathic and herbal medicinal products.
What is the definition of a medicinal product - part a and b?
a. Any substances or combination of substances presented as having properties of preventing or treating disease in human beings or
b. Any substance or combination of substances that may be used by or administered to human beings with a view to Restoring, correcting or modifying a physiological function by exerting a pharmacological, immunological or metabolic action or Making a medical diagnosis
A = presentation of the product
B = action of the product on the body - function
Human blood and nay human blood components are not included within the definition.
Who issues marketing authorisations and what do medicines need to show evidence of to get an MA?
Before a medicinal product can be marketed, sold, supplied or imported HMR states it must have a marketing authorisation (MA).
Any meds and appliances marketed, sold, supplied or imported to the UK have to been approved by a regulatory body which has evidence of their safety, quality and efficacy when used as specified in the MA.
MHRA responsible for issuing MA’s in the UK.
What are meds approved via EMA’s known as?
Meds which were approved via EMA’s centralised route known as centrally authorised products (CAPs) were converted into UK MA’s on the day we left EU and are still authorised unless CAP holder opted out of this.
Who has taken over the role of pharmacovigilance from EU agencies?
MHRA taken over role which EU agencies has in respect of pharmacovigilance.
How long is marketing authorisation (MA) granted for?
MA granted for 5 years
What do the MHRA need to satisfied with for meds to be granted and MA?
MA granted if MHRA satisfied that medicine is safe, effective and of a suitable quality. Not allowed to consider price only SAFETY, EFFICAY AND QUALITY.
What are the safety requirements for meds (3 things)?
Any risks to the person administering the product or, if it is a machine the person operating it.
Any danger to the health of the community
The extent which the product may interfere with treatment, diagnosis or prevention of disease.
No meds are completely safe, all meds have some undesirable effects, interactions with other meds or assoicated dangers when taken in overdose. Means MHRA must consider risks of meds and balance them against the benefits - known risk/benefit ratio.
What are the efficacy requirements for meds?
Efficacy means meds ‘does what it says on the tin’ it has its claimed benefits.
MA can’t be refused cus there is already another product available with greater efficacy.
What are the quality requirements for meds?
Agency must assess whether meds can be produced with sufficient quality assurance.
- Can applicant guarantee:
- SHELF LIFE
- CONSISTENT LEVELS OF ACTIVE INGREDIENT IN EACH DOSE
- LOW DEGRADATION.
What are the 2 documents in the electronic medicines compendium (emc)?
2 documents - summary of product characteristics (SmPC)/Patient information leaflet (PIL)
What is an electronic medicines compendium (emc)?
’ the electronic medicines compendium (emc) contains up to date, easily accessible information about medicines licence for use in the UK, emc has more than 14000 documents all of which has been checked and approved by either UK or European government agencies which license medicines. These agencies are the UK’ MHRA and the EMA.’
What is a summary of product characteristic (SmPC)?
A Summary of Product Characteristic (or SmPC) is a monograph for medicines written and updated by pharmaceutical companies based on their product research and knowledge. It outlines important information about medicines such as form, clinical parameters and pharmacological properties
What are patient information leaflets (PILs) used for?
The purpose of patient information leaflets (PILs) is to inform patients about the administration, precautions and potential side effects of their prescribed medication.